返回
Medigene AG（MDGEF）價格
MDGEF 股價走勢圖
MDGEF 股票價格預測
Medigene AG
$2.59
0%
$0
收盤價：Jan 16, 16:00:00 GMT-5
$2.59
0%
$0
盤後：Jan 16, 20:00:00 GMT-5
關鍵數據
前收市價
$2.59
開盤價
$2.59
當日範圍
$0.1 - $2.59
52週區間
$0.1 - $2.59
交易量
10.0K
平均成交量
0
每股盈餘 (TTM)
-1.28
股息收益率
--
市值
$38.1M
什麼是 MDGEF？
MediGene AG is a biotechnology company, which engages in developing innovative, complementary treatment platforms that target various types and stages of cancer. The company is headquartered in Planegg, Bayern and currently employs 86 full-time employees. The company went IPO on 2000-06-30. The firm focuses on the development of personalized T cell-based immunotherapies. The company develops three platforms: T-cell receptor (TCR)-modified T cells for adoptive T-cell therapy as treatments for patients with tumor burdens; Dendritic cell (DC) vaccines for the treatment of low tumor burdens, such as minimal residual disease or for use in combination therapies, and T-cell-specific monoclonal antibodies (TABS) to identify T cells based on their T-cell receptors. The firm operates offices in Martinsried in Germany, as well as in Washington DC and San Diego in the United States.